IMVT earnings: a positive outcome, +6.7%

On August 10, 2023, Immunovant, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.7% in the window around the event. It had already run +8.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.